Log In
Print
BCIQ
Print
Print this Print this
 

Dual TLR7 and TLR9 antagonist

  Manage Alerts
Collapse Summary General Information
Company Idera Pharmaceuticals Inc.
DescriptionDual toll-like receptor 7 (TLR7) and toll-like receptor 9 (TLR9) antagonist
Molecular Target
Mechanism of Action 
Therapeutic Modality 

 Product Details
Disease CategoryStandard IndicationIndication DetailsPartnersMilestonesLatest Stage of DevelopmentRegulatory Designation
 Archive Items are loading loading
Get a free BioCentury trial today